IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis

Immunoglobulin A (IgA) vasculitis is the most common systemic vasculitis in the pediatric population. We present the case of a patient with IgA vasculitis with nephritis who developed cytomegalovirus (CMV) infection followed by Mycobacterium tuberculosis infection. In the literature, there are a few...

Full description

Bibliographic Details
Main Authors: Małgorzata Mizerska-Wasiak, Maria Winiarska, Karolina Nogal, Karolina Cichoń-Kawa, Małgorzata Pańczyk-Tomaszewska, Jadwiga Małdyk
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pediatric Reports
Subjects:
Online Access:https://www.mdpi.com/2036-7503/13/3/48
_version_ 1797517648876011520
author Małgorzata Mizerska-Wasiak
Maria Winiarska
Karolina Nogal
Karolina Cichoń-Kawa
Małgorzata Pańczyk-Tomaszewska
Jadwiga Małdyk
author_facet Małgorzata Mizerska-Wasiak
Maria Winiarska
Karolina Nogal
Karolina Cichoń-Kawa
Małgorzata Pańczyk-Tomaszewska
Jadwiga Małdyk
author_sort Małgorzata Mizerska-Wasiak
collection DOAJ
description Immunoglobulin A (IgA) vasculitis is the most common systemic vasculitis in the pediatric population. We present the case of a patient with IgA vasculitis with nephritis who developed cytomegalovirus (CMV) infection followed by Mycobacterium tuberculosis infection. In the literature, there are a few cases of IgA nephropathy accompanied by reactivation of CMV or tuberculosis. To the best of our knowledge, this is the first reported case of IgA vasculitis complicated by both CMV reactivation and tuberculosis. It is important to detect infections in patients with IgA vasculitis because they can induce and exacerbate the symptoms of the disease. Effective antimicrobial treatment facilitates the management of proteinuria and slows down the decline of renal function. Immunosuppressive therapy is a risk factor for reactivation of latent infections and makes patients more susceptible to its generalized and complicated course. This can be prevented by actively screening for hidden sites of infection.
first_indexed 2024-03-10T07:19:28Z
format Article
id doaj.art-9f377558fe4c474983b2f457ff0603f9
institution Directory Open Access Journal
issn 2036-7503
language English
last_indexed 2024-03-10T07:19:28Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Pediatric Reports
spelling doaj.art-9f377558fe4c474983b2f457ff0603f92023-11-22T14:43:49ZengMDPI AGPediatric Reports2036-75032021-07-0113341642010.3390/pediatric13030048IgA Vasculitis Complicated by Both CMV Reactivation and TuberculosisMałgorzata Mizerska-Wasiak0Maria Winiarska1Karolina Nogal2Karolina Cichoń-Kawa3Małgorzata Pańczyk-Tomaszewska4Jadwiga Małdyk5Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, PolandStudent’s Scientific Group at the Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, PolandStudent’s Scientific Group at the Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Pathology, Medical University of Warsaw, 02-091 Warsaw, PolandImmunoglobulin A (IgA) vasculitis is the most common systemic vasculitis in the pediatric population. We present the case of a patient with IgA vasculitis with nephritis who developed cytomegalovirus (CMV) infection followed by Mycobacterium tuberculosis infection. In the literature, there are a few cases of IgA nephropathy accompanied by reactivation of CMV or tuberculosis. To the best of our knowledge, this is the first reported case of IgA vasculitis complicated by both CMV reactivation and tuberculosis. It is important to detect infections in patients with IgA vasculitis because they can induce and exacerbate the symptoms of the disease. Effective antimicrobial treatment facilitates the management of proteinuria and slows down the decline of renal function. Immunosuppressive therapy is a risk factor for reactivation of latent infections and makes patients more susceptible to its generalized and complicated course. This can be prevented by actively screening for hidden sites of infection.https://www.mdpi.com/2036-7503/13/3/48tuberculosisCMVIgA nephropathyIgA vasculitisproteinuriaimmunosuppressive therapy
spellingShingle Małgorzata Mizerska-Wasiak
Maria Winiarska
Karolina Nogal
Karolina Cichoń-Kawa
Małgorzata Pańczyk-Tomaszewska
Jadwiga Małdyk
IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
Pediatric Reports
tuberculosis
CMV
IgA nephropathy
IgA vasculitis
proteinuria
immunosuppressive therapy
title IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
title_full IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
title_fullStr IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
title_full_unstemmed IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
title_short IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
title_sort iga vasculitis complicated by both cmv reactivation and tuberculosis
topic tuberculosis
CMV
IgA nephropathy
IgA vasculitis
proteinuria
immunosuppressive therapy
url https://www.mdpi.com/2036-7503/13/3/48
work_keys_str_mv AT małgorzatamizerskawasiak igavasculitiscomplicatedbybothcmvreactivationandtuberculosis
AT mariawiniarska igavasculitiscomplicatedbybothcmvreactivationandtuberculosis
AT karolinanogal igavasculitiscomplicatedbybothcmvreactivationandtuberculosis
AT karolinacichonkawa igavasculitiscomplicatedbybothcmvreactivationandtuberculosis
AT małgorzatapanczyktomaszewska igavasculitiscomplicatedbybothcmvreactivationandtuberculosis
AT jadwigamałdyk igavasculitiscomplicatedbybothcmvreactivationandtuberculosis